Carterra: High Throughput Antibody Screening & Characterization
carterra-bio.com
Actively hiring
Biologics & Biosimilars
Health Care
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
The biotech bi-weekly: a 48-channel SPR platform, robust RNA-seq libraries and microgravitational discoveries
Here are the latest biotech industry updates: introducing new platforms for SPR, RNA-seq libraries and DNA extraction.
Read more
Report
Carterra Launches Industry's First 48-channel HT-SPR Platform
9 February 2026 -- Utah, US -- Carterra Inc., the leading provider of technologies enabling high-throughput biology, today announced the launch of the Carterra Vega High-Throughput Surface Plasmon Resonance (HT-SPR) instrument.
Read more
Report
Carterra launches industry's first 48-channel HT-SPR platform for advanced label-free biomolecular screening and characterization Cambridge Network
Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional and AI-based drug discovery Enables primary screening with high-resolution binding First order and shipment slated for Q1 will be to a KOL at a top 10
Read more
Report